The antinociceptive effect of zolpidem and zopiclone in mice

Pharmacology Biochemistry and Behavior

Volumn 81, Issue 3, 2005, Pages 417-423

  Pick, Chaim G ^a   Chernes, Yakov ^b   Rigai, Tova ^a   Rice, Kenner C ^c   Schreiber, Shaul ^d  

^a TEL AVIV UNIVERSITY   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^d TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Antinociception; Drugs interaction; Hotplate; Mice; Opioids; Zolpidem; Zopiclone

Indexed keywords

4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 METHOXYBENZYL] N,N DIETHYLBENZAMIDE; ALPHA 2 ADRENERGIC RECEPTOR; CLONIDINE; MORPHINE; NALOXONE; OPIATE RECEPTOR; SEROTONIN; SEROTONIN RECEPTOR; YOHIMBINE; ZOLPIDEM; ZOPICLONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DETERMINATION; DRUG MEGADOSE; HOT PLATE TEST; HYPERALGESIA; INHIBITION KINETICS; MALE; MOUSE; NONHUMAN; PAIN; PALLIATIVE THERAPY; PRIORITY JOURNAL; SLEEP INDUCTION; STATISTICAL SIGNIFICANCE;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ADRENERGIC AGONISTS; ADRENERGIC ANTAGONISTS; ANALGESICS; ANIMALS; BEHAVIOR, ANIMAL; BENZAMIDES; CLONIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPNOTICS AND SEDATIVES; MALE; MICE; MICE, INBRED ICR; MORPHINE; NALOXONE; PAIN; PAIN MEASUREMENT; PIPERAZINES; PYRIDINES; RECEPTORS, OPIOID; SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS;

EID: 22044434990     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2005.02.013     Document Type: Article

References (53)

1. H. Allain, and J. Monti General safety profile of zolpidem: safety in elderly, overdose and rebound effects Eur Psychiatr 11 1996 4655 4735
2. M. Ansseau, W. Pitchot, M. Hansenne, and A. Gonzalez Moreno Psychotic reactions to zolpidem Lancet 339 1992 809
3. H. Ashton Guidelines for the rational use of benzodiazepines: when and what to use Drugs 48 1994 25 40
4. M. Boixet, E. Battle, and I. Bolibar Benzodiazepines in primary health care: a survey of general practitioners prescribing patterns Addiction 91 1996 549 556
5. U.E. Busto, B.A. Sproule, K. Knight, and N. Herrmann Use of prescription and nonprescription hypnotics in a Canadian elderly population Can J Clin Pharmacol 8 2001 213 221
6. J.N. Carlson, R. Haskew, J. Wacker, I.M. Maisonneuve, S.D. Glick, and T.P. Jerussi Sedative and anxiolytic effects of zopiclone's enantiomers and metabolite Eur J Pharmacol 415 2001 181 189
7. H. Chevalier, F. Los, D. Boichut, M. Bianchi, D.J. Nutt, and G. Hajak Evaluation of severe insomnia in the general population: results of a European multinational survey J Psychopharmacol 13 1999 S21 S24
8. Clarenbach P, Steinberg R, Weeß HG, Berger M, with the assistance of Hajak G, Mayer G, Penzel T, Peter JH, Schläfke ME. Recommendations for the diagnosis and therapy of insomnia. German Society of Sleep Research and Sleep Medicine. Nervenarzt. 1995;66:723-9.
9. W.B. Clee, A.J. McBride, and G. Sullivan Warning about zopiclone misuse Addiction 91 1996 1389 1390
10. A. Concas, M. Serra, G. Santoro, E. Maciocco, T. Cuccheddu, and G. Biggio The effect of cyclopyrrolones on GABAA receptor function is different from that of benzodiazepines Naunyn Schmiedebergs Arch Pharmacol 350 1994 294 300
11. G. Darcourt, D. Pringuey, D. Salliere, and J. Lavoisy The safety and tolerability of zolpidem-an update J Psychopharmacol 13 1999 81 93
12. M. Davies, J.G. Newell, J.M. Derry, I.L. Martin, and S.M. Dunn Characterization of the interaction of zopiclone with gamma-aminobutyric acid type A receptors Mol Pharmacol 58 2000 756 762
13. M. Dooley, and G.L. Plosker Zaleplon: a review of its use in the treatment of insomnia Drugs 60 2000 413 445
14. D.J. Dooley, C.A. Mieske, and S.A. Borosky Inhibition of K(+)-evoked glutamate release from rat neocortical and hippocampal slices by gabapentin Neurosci Lett 18 280 2000 107 110
15. K.L. Goa, and R.C. Heel Zopiclone-a review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy as a hypnotic Drugs 32 1986 48 65 [updated 1991]
16. G. Hajak A comparative assessment of the risks and benefits of zopiclone: a review of 15 years' clinical experience Drug Saf 21 1999 457 469
17. G. Hajak On behalf of the SINE Study Group Epidemiology of severe insomnia and its consequences in Germany Eur Arch Psychiatry Clin Neurosci 251 2001 49 56
18. G. Hajak, W.E. Müller, H.U. Wittchen, D. Pittrow, and W. Kirch Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data Addiction 98 2003 1371 1378
19. K.J. Holm, and K.L. Goa Zolpidem. An update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia Drugs 59 2000 865 889
20. H.K. Im, W.B. Im, B.J. Hamilton, D.B. Carter, and P.F. Vonvoigtlander Potentiation of gamma-aminobutyric acid-induced chloride currents by various benzodiazepine site agonists with the alpha 1 gamma 2, beta 2 gamma 2 and alpha 1 beta 2 gamma 2 subtypes of cloned gammaaminobutyric acid type A receptors Mol Pharmacol 44 1993 866 870
21. J. Jessop, and J.G. Jones Evaluation of the action of general anaesthetics in the human brain Gen Pharmacol 23 1992 927 935
22. M. Lader Zopiclone: is there any dependence and abuse potential? J Neurol 244 1997 S18 S22
23. M.H. Lader Limitations on the use of benzodiazepines in anxiety and insomnia: are they justified? Eur Neuropsychopharmacol 9 1999 S399 S405
24. M. Lader, and J. Russel Guidelines for the prevention and treatment of benzodiazepine dependence: summary of a report from the Mental Health Foundation Addiction 88 1993 1707 1708
25. S.Z. Langer, and S. Arbilla Limitations of the benzodiazepine receptor nomenclature: a proposal for a pharmacological classification as omega receptor subtypes Fundam Clin Pharmacol 2 1988 159 170
26. S.Z. Langer, S. Arbilla, S. Tan, K.G. Lloyd, P. George, and J. Allen Selectivity for omega-receptor subtypes as a strategy for the development of anxiolytic drugs Pharmacopsychiatry 23 Suppl. 3 1990 103 107
27. H.D. Langtry, and P. Benfield Zolpidem: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential Drugs 40 1990 291 313
28. C. Lennmarken, K. Bildfors, G. Enlund, P. Samuelsson, and R. Sandin Victims of awareness Acta Anaesthesiol Scand 46 2002 229 231
29. P. Lillsunde, and T. Seppälä Simultaneous screening and quantitative analysis of benzodiazepines by dual channel gas chromatography using electron-capture and nitrogen-phosphorus detection J Chromatogr 533 1990 97 110
30. J.S. Markowitz, and T.D. Brewerton Zolpidem-induced psychosis Ann Clin Psychiatry 8 1996 89 91
31. W.B. Mendelson, T. Roth, J. Cassella, T. Roehrs, J.K. Walsh, and J.H. Woods The treatment of chronic insomnia: drug indications, chronic use and abuse liability. Summary of a 2001 New Clinical drug Evaluation Unit Meeting Symposium Sleep Med Rev 8 2004 7 17
32. K.V. Nemmani, and J.S. Mogil Serotonin-GABA interactions in the modulation of mu- and kappa-opioid analgesia Neuropharmacology 44 2003 304 310
33. D.N. Neubauer Pharmacologic approaches for the treatment of chronic insomnia Clin Cornerstone 5 2003 16 27
34. M.M. Ohayon, and J. Zulley Correlates of global sleep dissatisfaction in the German population Sleep 24 2001 780 787
35. J.E. Osterman, J. Hopper, W.J. Heran, T.M. Keane, and B.A. van der Kolk Awareness under anesthesia and the development of posttraumatic stress disorder Gen Hosp Psychiatry 23 2001 198 204
36. C.G. Pick Strain differences in mice antinociception: relationship between alprazolam and opioid receptor subtypes Eur Neuropsychopharmacol 6 1996 201 205
37. C.G. Pick Antinociceptive interaction between alprazolam and opioids Brain Res Bull 42 1997 239 243
38. S. Rooney, and J.J. O'Conner Zopiclone, a current drug of misuse Addiction 93 1999 925
39. J.H. Rosland, and K. Hole 1,4-Benzodiazepines antagonize opiate-induced antinociception in mice Anesth Analg 71 1990 242 248
40. C.R. Rush Behavioral pharmacology of zolpidem relative to benzodiazepines: a review Pharmacol Biochem Behav 61 1998 253 269
41. D.J. Sanger, J. Benavides, G. Perrault, E. Morel, C. Cohen, and D. Joly Recent developments in the behavioral pharmacology of benzodiazepine (omega) receptors: evidence for the functional significance of receptor subtypes Neurosci Biobehav Rev 18 1994 355 372
42. D.J. Sanger, J. Benavides, G. Perrault, M. Soyka, R. Bottlender, and H.J. Möller Epidemiological evidence for a low abuse potential of zolpidem Pharmacopsychiatry 33 2000 138 141
43. S. Schreiber, T. Rigai, Y. Katz, and C.G. Pick The antinociceptive effect of mirtazapine in mice is mediated through serotonergic, noradrenergic and opioid mechanisms Brain Res Bull 58 2002 599 603
44. S. Schreiber, A. Bleich, and C.G. Pick Venlafaxine and mirtazapine: Different mechanisms of antidepressant action, common opioid-mediated antinociceptive effects-a possible opioid involvement in severe depression? J Mol Neurosci 18 2002 143 147
45. S.H. Stewart, and H.A. Westra Benzodiazepine side-effects: from the bench to the clinic Curr Pharm Des 8 2002 1 3
46. R.J. Tallarida, and R.B. Murray Manual of pharmacological calculations with computer programs 1987 Springer New York
47. M. Unden, Roth, and B. Schechter Next day effects after nighttime with zolpidem. A review Eur Psychiatry 11 1996 21S 30S
48. B.W. Urban, and P. Friederich Anesthetic mechanisms in vitro and in general anesthesia Toxicol Lett 100 1998 9 16
49. J.C. Verster, D.S. Veldhuijzen, and E.R. Volkerts Residual effects of sleep medication on driving ability Sleep Med Rev 8 2004 309 325
50. A.N. Wadworth, and D. McTavish Zopiclone-review of its pharmacological properties and therapeutic efficacy as a hypnotic Drugs Aging 3 1993 441 459
51. R. Weizman, L. Paz, Y.P. Peter, Toren, and C.G. Pick Behavioral effects of agents active at the gamma-amino butyric acid receptor complex in the staircase paradigm Brain Res 901 2001 137 142
52. H.U. Wittchen, P. Krause, M. Höfler, S. Winter, B. Spiegel, and G. Hajak NISAS-2000: Die 'Nationwide Insomnia Screening and Awareness Study'. Insomnien und Schlafstörungen in der allgemeinärztlichen Versorgung [NISAS-2000: The 'Nationwide Insomnia Screening and Awareness Study'. Prevalence and interventions in primary care] Nervenheilkunde 20 2001 4 16
53. F. Zambotti, N. Zonta, R. Tammiso, F. Conci, B. Hafner, and P. Ferrario Zopiclone potentiates the antinociceptive effect of morphine in rats Naunyn Schmiedebergs Arch Pharmacol 336 1987 526 529